Corrigendum to "Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease" [Clin. Mass Spectrom. 14 (Part B) (2019) 74-82]

J Mass Spectrom Adv Clin Lab. 2022 Sep 28:26:35. doi: 10.1016/j.jmsacl.2022.08.002. eCollection 2022 Nov.

Karl Hansson¹, Rahil Dahlén¹, Oskar Hansson^{2

3}, Elin Pernevik¹, Ross Paterson⁴, Jonathan M Schott⁴, Nadia Magdalinou⁵, Henrik Zetterberg^{1

6}, Kaj Blennow^{1

6}, Johan Gobom^{1

6}

¹ Institute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
² Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
³ Memory Clinic, Skåne University Hospital, Malmö, Sweden.
⁴ Dementia Research Centre, UCL Institute of Neurology, London, UK.
⁵ Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, Queen Square, London, UK.
⁶ Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.

Abstract

[This corrects the article DOI: 10.1016/j.clinms.2019.07.002.].